(a) the number of clinical trials of drugs/ vaccines presently being hosted by the country;
(b) whether the drug manufacturing industry has witnessed a slowdown on account of stringent/ unfavourable provisions relating to clinical trial and pharmaceutical products approval mechanism;
(c) if so, the details thereof indicating the number of applications for conduct of clinical trials of drugs/vaccines received indicating the number out of them approved during each of the last three years and the current year;
(d) whether the Government proposes to put in place a regulatory pathway to enable technical deliberations between the drug regulator and stakeholders to address concerns before the companies make formal application seeking product approvals or permission for clinical trails, and if so, the details thereof; and
(e) the other measures being taken by the Government for speedy approval of applications for clinical trials?